Indication

Ocular rosacea

Ocular rosacea is a chronic inflammatory disorder of the ocular surface and adnexa, representing a major subtype of rosacea that commonly affects adults with cutaneous rosacea, though it can also develop independently. Read more about Ocular rosacea

23 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Ocular rosacea therapies.

Showing 19–23 of 23 drugs

Filter & compare in the drug finder →Opens the drug finder with Ocular rosacea preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Ocular rosacea.

Ocular rosacea is a chronic inflammatory disorder of the ocular surface and adnexa, representing a major subtype of rosacea that commonly affects adults with cutaneous rosacea, though it can also develop independently.

Pathophysiologically driven by neurovascular dysregulation, immune-mediated inflammation, and meibomian gland dysfunction, the condition impairs tear film stability.

Clinical manifestations typically include blepharitis, conjunctival hyperemia, lid margin telangiectasias, recurrent chalazia or hordeola, foreign-body sensation, and dry eye disease.

If untreated, severe or progressive disease can lead to sight-threatening complications such as chronic keratitis, corneal neovascularization, ulceration, and perforation.

Personalize your experience

Follow Ocular rosacea and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it